H19 lnc RNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis

• Published in: EMBO molecular medicine Vol. 7; no. 8; pp. 996 - 1003
• Main Authors: Ghazal, Sanaz, McKinnon, Brett, Zhou, Jichun, Mueller, Martin, Men, Yi, Yang, Lihua, Mueller, Michael, Flannery, Clare, Huang, Yingqun, Taylor, Hugh S
• Format: Journal Article
• Language: English
• Published: Frankfurt EMBO Press 01.08.2015
• Subjects: Bioavailability; Cell growth; Cell proliferation; Chronic pain; Drug development; Endometriosis; Endometrium; Experiments; Gene expression; Infertility; Insulin; Insulin-like growth factors; Menstruation; MicroRNAs; miRNA; Molecular modelling; Physiology; Pregnancy; Signal transduction; Software; Stromal cells; Transcription
• ISSN: 1757-4676; 1757-4684
• DOI: 10.15252/emmm.201505245

Endometriosis affects approximately 15% of reproductive aged women and is associated with chronic pelvic pain and infertility. However, the molecular mechanisms by which endometriosis impacts fertility are poorly understood. The developmentally regulated, imprinted H19 long noncoding RNA (lncRNA) functions to reduce the bioavailability of microRNA let‐7 by acting as a molecular sponge. Here we report that H19 expression is significantly decreased in the eutopic endometrium of women with endometriosis as compared to normal controls. We show that decreased H19 increases let‐7 activity, which in turn inhibits Igf1r expression at the post‐transcriptional level, thereby contributing to reduced proliferation of endometrial stromal cells. We propose that perturbation of this newly identified H19/Let‐7/IGF1R regulatory pathway may contribute to impaired endometrial preparation and receptivity for pregnancy in women with endometriosis. Our finding represents the first example of a lncRNA‐based mechanism in endometriosis and its associated infertility, thus holding potential in the development of novel therapeutics for women with endometriosis and infertility.